Cagrilintide + Semaglutide (5mg + 5mg)
- Name: CS10 Peptide Blend
- Components: 5mg Cagrilintide + 5mg Semaglutide per vial
- Quantity: 10 mg total (lyophilised powder)
- Formulation: Dual‑peptide lyophilised blend
Key Features
- Purity: ≥ 98.0% (HPLC‑verified)
- Endotoxin: ≤ 5 EU/mg
- Form: Freeze‑dried (lyophilised) powder for stability
- Documentation: Certificate of Analysis (COA) supplied with every lot
Peptide Information
- Cagrilintide (5mg):
- Amylin analog peptide
- Investigated for appetite regulation and satiety signaling
- Semaglutide (5mg):
- GLP‑1 receptor agonist peptide
- Studied for glycemic control and weight management
Storage & Stability
- Long‑term: –20 °C, dry and desiccated
- Short‑term: Stable at 2–8 °C
- Handling Note: Avoid repeated freeze–thaw cycles
Intended Use
- For laboratory research only
- Not for human or veterinary use
- Not approved for diagnostic, therapeutic, or medical applications
- Must be handled using appropriate laboratory safety practices
Why Choose CS10 (5mg + 5mg)?
- Dual‑peptide synergy for advanced metabolic research
- High purity suitable for sensitive experimental systems
- Full batch traceability with COA included
- Lyophilised for extended shelf stability
| Weight | 100 g |
|---|---|
| Dimensions | 1 × 1 × 3 cm |
